16 November 2020 Step up for TB 2020 - Social Media Gallery, Animated Images Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Each and every one of the 1.4 million deaths caused by TB in 2019 could have been prevented. The #StepUpForTB report analyses policies for tackling TB in 37 high-burden countries.⬇️ https://msfaccess.org/stepupfortb Tweet this Children are especially vulnerable to #tuberculosis. In 2019, 1.2 million children fell sick with TB. Children with TB deserve access to effective treatments free of toxic drugs that have to be injected. https://msfaccess.org/stepupfortb Tweet this It’s time for change. Governments need to ensure that critical innovations in TB treatment, diagnostics and prevention reach the people who need them. Read our report how governments can Step Up for TB! ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this ⏲️ ⏲️ It’s time for change. Countries CAN stop deaths from TB. This is achievable if policies are rapidly updated and implemented at scale. Read the report ⬇️ #StepUpForTB https://msfaccess.org/stepupfortb Tweet this Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min Photo credit: Lana Abramova Press release Press release | 23 April 2024 Diagnostics As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries 2 min Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test Photo credit: MSF/Johnny Vianney Bissakonou Press release Press release | 15 April 2024 Vaccines As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination 3 min Letter | 08 April 2024 Diagnostics Tuberculosis Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test Letter | 02 April 2024 Diagnostics Tuberculosis Sierra Leone Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test Letter | 02 April 2024 Diagnostics Tuberculosis Belarus Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test Load More
Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit
Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min
Photo credit: Lana Abramova Press release Press release | 23 April 2024 Diagnostics As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries 2 min
Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test
Photo credit: MSF/Johnny Vianney Bissakonou Press release Press release | 15 April 2024 Vaccines As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination 3 min
Letter | 08 April 2024 Diagnostics Tuberculosis Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test
Letter | 02 April 2024 Diagnostics Tuberculosis Sierra Leone Sierra Leone: National TB Programme letter to Danaher to reduce the price of GeneXpert test
Letter | 02 April 2024 Diagnostics Tuberculosis Belarus Belarus: National TB Programme letter to Danaher to reduce the price of GeneXpert test